Challenges in clinical studies in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Challenges in clinical studies in Brazil

Challenges in clinical studies in Brazil – Clinical Trials in LATAM

Clinical studies play a crucial role in advancing medical knowledge and improving patient care. However, conducting clinical trials in Brazil presents unique challenges that must be addressed to ensure their success. This blog post will explore the key hurdles faced by researchers in Brazil and discuss potential solutions to overcome them.

By understanding these challenges and finding innovative ways to navigate them, we can create an environment conducive to effective and efficient clinical research in Brazil, leading to improved healthcare outcomes and benefiting both the population and the global medical community.

Regulatory Framework and Ethical Oversight

Navigating the regulatory landscape is a significant challenge in conducting clinical studies in Brazil. Researchers must comply with strict regulations set by the Brazilian Health Regulatory Agency (ANVISA) and obtain approvals from ethics committees.

Lengthy approval processes, inconsistent interpretation of regulations, and a lack of transparency can result in delays and bureaucratic hurdles. Streamlining the regulatory procedures, enhancing communication between regulatory bodies and researchers, and providing clearer guidelines can expedite approvals while ensuring the ethical integrity of clinical trials.

Patient Recruitment and Retention

Recruiting and retaining participants for clinical trials is a common challenge globally, and Brazil is no exception. Factors such as limited awareness, geographic dispersion, and socioeconomic disparities can hinder patient enrollment. Building partnerships with healthcare providers, implementing targeted awarenes campaigns, and engaging with patient advocacy groups can help address these challenges.

Additionally, offering incentives, ensuring convenient trial locations, and providing support systems for participants can improve retention rates and enhance the diversity of the study population.

Infrastructure and Research Capacity

Insufficient infrastructure and limited research capacity pose significant hurdles to clinical studies in Brazil. Inadequate funding, outdated facilities, and a shortage of skilled researchers can impact the quality and efficiency of trials. To address these challenges, investments in research infrastructure, public-private collaborations, and training programs for researchers should be prioritized.

Enhancing research capacity can attract more trials, encourage international collaborations, and promote the generation of high-quality data. Additionally, fostering innovation in research practices and promoting interdisciplinary collaboration can further strengthen Brazil’s research capabilities.

Challenges in clinical studies in Brazil

Challenges in clinical studies in Brazil

Challenges in clinical studies in Brazil

Data Management and Collaboration

Effective data management and collaboration are critical for successful clinical studies. Brazil faces challenges in data collection, storage, and analysis, particularly in multi-center trials. Fragmented data collection systems, limited access to electronic medical records, and varying data quality can hinder research progress.

Implementing standardized data management protocols, establishing robust data management systems, and promoting collaboration among research institutions can address these challenges. Encouraging data sharing initiatives, leveraging technology for data integration, and fostering a culture of collaboration can enhance knowledge exchange and accelerate research outcomes.

Socioeconomic and Cultural Considerations

Socioeconomic factors and cultural diversity present unique challenges in clinical studies in Brazil. Socioeconomic disparities can affect patient access to trials, adherence to study protocols, and generalizability of study results. Understanding the cultural context, engaging with local communities, and tailoring study designs to accommodate cultural beliefs and practices can improve patient engagement and study outcomes.

Collaborating with community leaders, patient advocacy groups, and social organizations can facilitate trust-building, enhance recruitment efforts, and promote inclusivity in clinical research.


Overcoming the challenges in clinical studies in Brazil requires concerted efforts from researchers, regulatory bodies, healthcare providers, and the community. By addressing regulatory complexities, implementing targeted patient recruitment strategies, investing in research infrastructure, improving data management systems, and considering socioeconomic and cultural factors,

Brazil can foster a favorable environment for high-quality clinical research. Collaborative initiatives, knowledge exchange, and capacity-building endeavors will not only benefit the Brazilian healthcare system but also contribute to global medical advancements. By doing so, Brazil can position itself as a leader in clinical research, attracting international collaborations and contributing to the development of innovative treatments and improved healthcare outcomes.

Challenges in clinical studies in Brazil

Source: Duke Clinical Research Institute

Challenges in clinical studies in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Challenges in clinical studies in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Challenges in clinical studies in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Challenges in clinical studies in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Challenges in clinical studies in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Challenges in clinical studies in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Challenges in clinical studies in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Challenges in clinical studies in Brazil

The Cohortias Team

Challenges in clinical studies in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Challenges in clinical studies in Brazil

Network & Partnerships